Lifestyle Medicine and Chronic Obstructive Pulmonary Disease in Viet Nam: Pulmonary Rehabilitation, Smoking Cessation, and Environmental Exposures

Lifestyle Medicine and Chronic Obstructive Pulmonary Disease in Viet Nam: Pulmonary Rehabilitation, Smoking Cessation, and Environmental Exposures

Primary category: Evidence & Clinical Practice

Secondary category: Health Equity & Planetary Health

Article type: VLMA Perspective

Last reviewed: October 30, 2026

For someone living with chronic obstructive pulmonary disease, a short walk to the local market may no longer be a simple part of the day. Climbing stairs, carrying groceries, or keeping up with family members can become increasingly difficult. Some people gradually stop doing activities they once enjoyed, not because they have lost interest, but because they are afraid of becoming breathless.

Avoiding activity may seem reasonable when breathing is uncomfortable. Yet prolonged inactivity can contribute to muscle weakness and reduced physical capacity, making everyday tasks even harder. As confidence declines, patients may become increasingly dependent on others, even when some of their functional limitations could potentially be improved through appropriate treatment and rehabilitation.

The usual advice is familiar: stop smoking, exercise regularly, eat well, and avoid polluted air. These recommendations have value, but they do not adequately describe what people living with chronic obstructive pulmonary disease need. Effective care requires an accurate diagnosis, appropriate respiratory treatment, ongoing assessment, and support that considers both the disease and its effects on everyday life.

Lifestyle Medicine can contribute through tobacco cessation, physical activity, nutritional support, health behavior change, and efforts to reduce harmful environmental exposures. These interventions, however, need to be understood within the broader framework of respiratory medicine. Their benefits, limitations, and safety requirements are not the same for every patient.

This is particularly relevant in Viet Nam following the Ministry of Health's updated national guideline for chronic obstructive pulmonary disease, issued in July 2026. The guideline recognizes pulmonary rehabilitation, nutrition, and supportive care as important components of comprehensive management.

For the Vietnam Lifestyle Medicine Alliance (VLMA), chronic obstructive pulmonary disease provides a useful example of how evidence-based Lifestyle Medicine can contribute to chronic disease care while respecting clinical responsibilities, professional boundaries, and the circumstances in which people live.

Understanding COPD Before Considering Lifestyle Interventions

Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition characterized by persistent respiratory symptoms and airflow obstruction associated with abnormalities of the airways and lungs. Common symptoms include breathlessness, chronic cough, sputum production, and fatigue, although their severity and effects on daily functioning vary considerably.

The burden of COPD remains substantial worldwide. According to the World Health Organization's fact sheet updated on June 10, 2026, COPD was the third leading cause of death globally, accounting for approximately 3.4 million deaths in 2023.

Although there is currently no cure for established COPD, appropriate treatment can improve symptoms, exercise tolerance, and quality of life while helping prevent exacerbations and other complications. Some patients remain relatively stable over extended periods, whereas others experience recurrent worsening of respiratory symptoms that may require additional treatment or hospitalization.

Diagnosis should not be based on symptoms or exposure history alone. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2026 report recommends considering COPD in people with compatible respiratory symptoms, recurrent lower respiratory tract infections, or relevant exposure histories. Confirmation requires spirometry demonstrating persistent airflow obstruction after bronchodilator administration, conventionally defined by a ratio of forced expiratory volume in one second to forced vital capacity below 0.70, interpreted within the clinical context.

Breathlessness can also result from asthma, cardiovascular disease, bronchiectasis, and other respiratory or systemic conditions. Some patients have more than one contributing problem. A history of smoking may increase suspicion of COPD, but it does not establish the diagnosis, and the absence of smoking does not exclude the disease.

These considerations are important when patients seek lifestyle advice before receiving a proper clinical assessment. Exercise, nutrition, and smoking cessation may offer general health benefits, but they cannot substitute for identifying the cause of respiratory symptoms and providing appropriate treatment.

For people with confirmed COPD, Lifestyle Medicine should be understood as a contribution to comprehensive care rather than an approach capable of reversing established emphysema or restoring normal lung function.

Pulmonary Rehabilitation Is More Than an Exercise Program

Pulmonary rehabilitation is one of the most established nonpharmacological interventions in COPD management. It addresses a problem that medication alone may not fully resolve: the effect of chronic respiratory disease on physical capacity, confidence, and participation in everyday activities.

A patient may receive appropriate inhaled treatment yet continue to avoid walking because of breathlessness. Over time, reduced movement can contribute to muscle deconditioning, making physical exertion increasingly difficult. Pulmonary rehabilitation can help address this cycle through an individualized, structured intervention.

The American Thoracic Society and European Respiratory Society definition, reflected in Viet Nam's 2026 COPD guideline, describes pulmonary rehabilitation as a comprehensive intervention based on thorough patient assessment, followed by individualized treatment that includes exercise training, education, and behavior-change support. Its purpose is to improve physical and psychological functioning and encourage long-term adherence to health-enhancing behaviors.

A comprehensive program commonly includes endurance training, resistance exercises, education, and strategies for symptom management and self-management. Depending on the patient's condition, professionals may also address breathing strategies, energy conservation, psychological concerns, and confidence in daily activities.

The American Thoracic Society's 2023 clinical practice guideline strongly recommends pulmonary rehabilitation for adults with stable COPD, based on moderate-quality evidence. It also strongly recommends rehabilitation following hospitalization for a COPD exacerbation.

Evidence supports improvements in exercise capacity, breathlessness, health-related quality of life, and functional performance. Pulmonary rehabilitation may also help reduce anxiety and depressive symptoms in some patients.

Importantly, these benefits do not necessarily require substantial improvement in spirometry. A person may continue to have persistent airflow obstruction but become better able to walk, climb stairs, manage household activities, or leave home independently.

Consider a patient who has stopped visiting friends because walking causes breathlessness. Simply recommending thirty minutes of daily exercise may do little to address the problem. The patient may need an assessment of respiratory symptoms, current treatment, exercise tolerance, oxygenation when indicated, muscle function, and associated medical conditions before receiving a suitable rehabilitation plan.

Through individualized training and support, the patient may gradually regain physical capacity and confidence. The goal is not to encourage exercise regardless of symptoms, but to improve function through a clinically appropriate and sustainable approach.

This also influences how rehabilitation outcomes should be evaluated. Changes in lung function remain clinically relevant, but they do not fully capture improvements in walking ability, symptoms, confidence, participation, and quality of life.

Pulmonary rehabilitation is an established component of respiratory and rehabilitation medicine. Its relationship with Lifestyle Medicine lies in shared approaches to physical activity, behavior change, patient education, and sustained self-management. Recognizing that relationship should not blur the distinct clinical expertise required to deliver rehabilitation safely.

Exercise Safety and the Importance of Individual Assessment

Remaining physically active is generally beneficial for people with COPD, but exercise recommendations need to reflect individual clinical circumstances.

A person who experiences mild breathlessness during longer walks may have very different needs from someone who becomes breathless while dressing or preparing meals. Cardiovascular disease, significant oxygen desaturation, musculoskeletal limitations, frailty, or other medical conditions may further influence exercise tolerance and safety.

Within pulmonary rehabilitation, exercise intensity and progression should be determined through appropriate clinical assessment and adjusted according to the patient's response. Walking, cycling, resistance training, and other activities may be used, but the most suitable combination depends on functional capacity, symptoms, associated conditions, and rehabilitation goals.

Some breathlessness during appropriately prescribed exercise may be expected. However, new chest pain, severe dizziness, unexpectedly intense breathlessness, or significant deterioration should prompt reassessment. Patients should not be encouraged to ignore concerning symptoms in pursuit of a predetermined exercise target.

A sudden worsening of respiratory symptoms also requires attention because an acute COPD exacerbation or another medical condition may be responsible. Such deterioration should not simply be interpreted as poor fitness or addressed through breathing exercises alone.

For healthcare professionals, the task is to distinguish between general advice to remain active and the need for structured rehabilitation supported by appropriate assessment and monitoring. Not every patient requires the same level of supervision, but exercise used as treatment must reflect the person's condition and the clinical responsibilities involved.

Recovery After a COPD Exacerbation

An exacerbation can affect patients long after the immediate respiratory episode has improved. Someone leaving the hospital may have less breathlessness than at admission but still experience fatigue, muscle weakness, reduced exercise tolerance, and anxiety about becoming unwell again.

Returning home does not necessarily mean returning to previous levels of functioning. Some patients become reluctant to walk outdoors or resume normal activities because they fear another exacerbation. Others struggle to manage medication, recognize worsening symptoms, or arrange follow-up appointments.

The American Thoracic Society recommends pulmonary rehabilitation following hospitalization for a COPD exacerbation. Evidence indicates that appropriately delivered rehabilitation can improve exercise capacity and health-related quality of life and reduce hospital readmissions.

Viet Nam's updated COPD guideline also recognizes the importance of pulmonary rehabilitation in recovery following an exacerbation. Its discussion of rehabilitation benefits includes a reduction in hospital admissions among patients who have recently recovered from an exacerbation.

The appropriate timing and intensity of rehabilitation depend on clinical stability, oxygenation, comorbidities, functional limitations, and the patient's ability to participate safely. Early rehabilitation may be appropriate for selected patients under professional supervision, but this should not be interpreted as an instruction for every patient to begin unsupervised exercise immediately after discharge.

Recovery planning should also address maintenance respiratory treatment, inhaler technique, medication adherence, vaccination, oxygen requirements when relevant, and arrangements for reassessment.

A written action plan may help patients recognize changes in symptoms and understand when to seek professional assistance. Such plans should be developed with the treating healthcare team and may include individualized instructions for managing worsening symptoms. They should not encourage patients to independently start antibiotics, systemic corticosteroids, oxygen therapy, or other treatments without appropriate clinical authorization and instructions.

For healthcare organizations, an important question is what happens after a patient leaves the hospital. Discharge documentation may confirm that acute treatment has been completed, but successful recovery also depends on whether patients can access the follow-up, rehabilitation, and ongoing support they need.

Smoking Cessation: An Essential Part of COPD Care

For people with COPD who smoke, stopping tobacco use remains one of the most important interventions for improving long-term respiratory outcomes.

Continued smoking contributes to further lung damage and can accelerate the decline in lung function. Smoking cessation can slow that decline and improve the long-term outlook, even when COPD has already been diagnosed.

A diagnosis of COPD does not mean that it is too late to stop smoking. However, successful cessation often requires more than explaining the consequences of continued tobacco use.

Nicotine dependence can involve physical addiction, established routines, emotional associations, and repeated unsuccessful attempts to quit. Some patients may understand the risks but struggle to maintain abstinence without professional support.

The World Health Organization's 2024 clinical treatment guideline recommends evidence-based behavioral interventions and appropriate pharmacological treatment. Behavioral support may include brief advice during healthcare encounters, individual or group counseling, and telephone-based services.

The guideline identifies nicotine replacement therapy, varenicline, bupropion, and cytisine among effective pharmacological options. Their use must reflect the patient's clinical circumstances and the regulatory status, availability, indications, contraindications, and precautions applicable in Viet Nam.

In Vietnamese practice, tobacco assessment should include cigarettes and traditional waterpipe tobacco, commonly known as thuốc lào, where relevant. Exposure to secondhand smoke is another consideration.

Electronic cigarettes and heated tobacco products should not be presented as treatments for COPD or recommended as tobacco cessation options in Viet Nam. National Assembly Resolution No. 173/2024/QH15 established prohibitions concerning these products from 2025, while Government Decree No. 90/2026/NĐ-CP introduced specific administrative sanctions for certain related violations, effective May 15, 2026.

These prohibited products should be distinguished from legally authorized medicines used for smoking cessation.

Supporting patients after an unsuccessful quit attempt is also important. A return to smoking may indicate ongoing dependence, difficulties with withdrawal, environmental influences, or insufficient support. Further assessment and treatment may be more constructive than assuming that the person lacks motivation.

In COPD management, tobacco cessation is an ongoing clinical priority, supported by appropriate treatment and follow-up rather than a single recommendation delivered at diagnosis.

COPD Is Not Exclusively a Smoker's Disease

Although tobacco smoking is a major cause of COPD, it is not the only contributor.

The World Health Organization recognizes household air pollution, occupational dust and fumes, early-life respiratory exposures, and genetic susceptibility among other important risk factors. Some individuals develop COPD despite never having smoked.

A person presenting with chronic cough or breathlessness should not be dismissed simply because they report no smoking history. Likewise, a COPD diagnosis should not automatically be interpreted as evidence that the person has smoked.

An appropriate exposure history may include previous and current occupations, the fuels used for cooking or heating, household ventilation, secondhand smoke, and prolonged contact with airborne dust or chemical fumes.

Factors affecting lung development early in life may also be relevant. Prematurity, impaired lung growth, and significant childhood respiratory illness can contribute to respiratory vulnerability later in life.

Recognizing these different pathways helps clinicians understand the disease more accurately and avoid unnecessary stigma. It also demonstrates why prevention cannot be based entirely on individual behavioral choices.

Environmental Exposures: When Individual Advice Is Not Enough

Reducing exposure to harmful airborne substances is relevant to both COPD prevention and the management of established disease. However, the most appropriate intervention depends on the source of exposure and the circumstances of the person affected.

Someone working in a dusty industrial environment may have limited ability to change their exposure independently. Effective protection may require workplace risk assessment, engineering controls, improved ventilation, appropriate protective equipment, or changes in working conditions.

A household using polluting cooking fuels may face different difficulties. Switching to cleaner alternatives can depend on affordability, housing arrangements, infrastructure, and access to suitable energy sources.

The World Health Organization's December 2025 fact sheet on household air pollution identifies exposure from polluting cooking and heating fuels as a contributor to several noncommunicable diseases, including COPD.

Outdoor air pollution presents another challenge. People living near busy roads, industrial activities, or other emission sources may not be able to control the surrounding air quality. Their opportunities to reduce exposure may also depend on where they work, travel, or spend time outdoors.

Clinicians may help patients identify relevant exposures and consider practical ways to reduce them. Depending on the circumstances, this might involve improving household ventilation, using cleaner cooking arrangements, seeking workplace protections, or adjusting outdoor activity during periods of particularly poor air quality.

Measures such as respiratory masks or indoor air filtration may have a role in selected situations, but their effectiveness depends on the type of pollutant, the equipment used, correct application, and the patient's circumstances. They should not be presented as universal solutions.

In Viet Nam, environmental exposures may differ substantially between urban, rural, household, and occupational settings. Their importance should be established through an appropriate history rather than assumed from a patient's place of residence or occupation alone.

A scientifically reasonable recommendation may be difficult to follow because of income, employment, housing, or access to safer alternatives. Patients should not be blamed for harmful exposures that they cannot independently remove. Meaningful risk reduction may require action from employers, healthcare services, communities, and public authorities alongside individual counseling.

This broader perspective is also reflected in the Lifestyle Medicine Core Competencies: 2025 Update, which strengthened attention to planetary health and introduced a competency addressing the social determinants of health. The update recognizes that effective lifestyle interventions need to consider the social and environmental conditions affecting patients' ability to make and sustain changes.

For Lifestyle Medicine, the implication is practical. Helping people protect their respiratory health sometimes requires attention to their working and living environments as much as to their personal habits.

Nutrition, Muscle Health, and Functional Capacity

Nutrition deserves attention in COPD because respiratory disease can affect nutritional status, body composition, and physical functioning.

Some patients experience unintended weight loss, reduced appetite, or muscle wasting. Others have overweight, obesity, diabetes, cardiovascular disease, or additional conditions that influence their nutritional requirements.

Breathlessness and fatigue may make meal preparation difficult. Some patients may also struggle to consume adequate food because eating itself becomes uncomfortable or tiring.

For patients with nutritional depletion or reduced muscle mass, appropriate nutritional support may help address deficiencies and contribute to rehabilitation. For those with obesity or cardiometabolic conditions, dietary counseling may need to balance nutritional adequacy with other treatment goals.

Body weight alone may not fully describe the patient's nutritional or functional status. Muscle strength and body composition can be especially relevant because skeletal muscle dysfunction contributes to exercise limitation in COPD.

Nutrition and rehabilitation may therefore need to be considered together, with professional assessment when indicated.

However, evidence supporting nutritional intervention in selected patients should not be interpreted as proof that a specific diet, supplement, or commercial product can reverse lung damage. Claims about lung cleansing, detoxification, or restoration of respiratory tissue require careful scientific scrutiny.

The appropriate nutritional approach should respond to the person's clinical and functional needs, not to a generalized lifestyle formula.

Self-Management and the Wider Experience of Living With COPD

People living with COPD make decisions about their health every day, often without a healthcare professional present.

They use prescribed inhalers, monitor symptoms, manage activity and rest, respond to environmental conditions, and decide when to seek assistance. These activities can influence treatment outcomes, but they require more than simply providing written information.

A patient may understand that an inhaler is important yet still use it incorrectly. Another may know that exacerbations are serious without recognizing the early symptoms that should prompt reassessment.

GOLD 2026 emphasizes the importance of self-management support and continuing communication with healthcare professionals. Education is valuable, but information alone does not necessarily produce sustained behavior change or better clinical outcomes.

Inhaler technique is a practical example. Even an appropriately prescribed medicine may provide less benefit when the device is not used correctly. Reviewing technique, identifying difficulties, and addressing adherence should therefore remain part of ongoing care.

Vaccination is another important component because respiratory infections can trigger exacerbations and serious illness. GOLD 2026 includes updated recommendations concerning influenza and respiratory syncytial virus, among other vaccines. Individual vaccination decisions should reflect age, clinical risk, current national guidance, product availability, and applicable requirements.

Self-management support should also help patients distinguish between expected day-to-day variation in symptoms and deterioration requiring medical attention. Marked worsening of breathlessness, new chest pain, confusion, or other concerning changes may indicate an exacerbation or another serious problem. These symptoms should not be managed solely through breathing exercises, relaxation techniques, or adjustments to daily routines.

Living with COPD also involves psychological and social challenges. Persistent breathlessness can create fear, frustration, and uncertainty. Some patients become concerned about future hospitalizations, dependence on family members, or their ability to continue working.

Anxiety and depression may affect treatment participation, physical activity, and quality of life. Pulmonary rehabilitation and suitable behavioral support may help some patients, but suspected mental health disorders still require appropriate professional assessment and treatment.

For people with advanced disease, palliative and supportive care may also be valuable. Such care is not limited to the final stage of life and may address persistent symptoms, psychological distress, communication, and quality of life alongside disease-directed treatment.

The overall objective is to help people participate meaningfully in their care while ensuring that clinical assessment, prescribing, and other regulated activities remain with appropriately authorized professionals.

What Recent Research From Viet Nam Suggests

International guidelines provide a scientific foundation for COPD management, but research from Vietnamese healthcare settings is needed to understand local implementation challenges.

A study by Phan, Vu, and Ngo, published in Tuberculosis and Respiratory Diseases in 2025, examined COPD management during the COVID-19 period in three COPD management units in Viet Nam.

The investigators enrolled 518 patients at baseline, of whom 352 remained in the final analysis following two years of follow-up. The study documented changes and challenges involving smoking, diagnostic investigations, treatment practices, and healthcare delivery during a period of significant disruption.

The findings provide useful insights into the participating services, but they require careful interpretation. The loss of 166 participants during follow-up, observational study design, and pandemic-related circumstances limit conclusions about causal effects or the quality of COPD management nationally.

A more recent study by Dang and colleagues, published in Pulmonary Medicine on September 6, 2026, investigated medication adherence and treatment-related outcomes among 400 patients with stable COPD receiving outpatient care at Kien Giang General Hospital.

The study reported an overall medication adherence rate of 76.5%, combining patients classified as having high and medium adherence under the researchers' scoring criteria. High adherence alone was reported in 46.3% of participants.

The investigators also found associations between adherence, smoking status, and their defined treatment-effectiveness outcome. The study classified 70.3% of participants as having improved according to a composite measure that required improvement in at least one assessed outcome. However, several comparisons of clinical measures between baseline and three-month follow-up did not reach statistical significance.

These findings should not be interpreted as proof that medication adherence or smoking status independently caused the observed outcomes. The study's observational design, short follow-up, and single-center population also limit the conclusions that can be generalized to Vietnamese COPD care more broadly.

Neither study provides a national assessment of access to pulmonary rehabilitation or a comprehensive evaluation of COPD services throughout Viet Nam.

Instead, they raise useful questions for clinical practice and health services research. Are eligible patients receiving appropriate spirometry? Can they obtain and correctly use prescribed inhalers? Is evidence-based tobacco cessation support available? Are patients who might benefit from pulmonary rehabilitation being identified and referred? What happens after the referral?

Answering these questions requires local service data, patient perspectives, and implementation research rather than assuming that the publication of a guideline guarantees its application in routine care.

Viet Nam's Updated COPD Guideline in 2026

An important development occurred on July 14, 2026, when the Ministry of Health issued Decision No. 2131/QĐ-BYT, promulgating the professional guideline Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease.

The decision took effect on the date of issuance, applies to medical examination and treatment facilities nationwide, and replaced Decision No. 2767/QĐ-BYT dated July 4, 2023.

The updated document provides a national professional reference covering diagnosis, clinical assessment, medical treatment, exacerbations, associated conditions, and supportive interventions.

Of particular relevance to Lifestyle Medicine, Chapter 5 addresses pulmonary rehabilitation, nutrition, and palliative care.

The guideline describes pulmonary rehabilitation as a comprehensive intervention that begins with patient assessment and includes individualized exercise training, education, and self-management support. It also provides practical materials, including guidance on inhaler use, patient action plans, an example of an eight-week rehabilitation program, and the six-minute walk test.

The guideline recognizes different approaches to rehabilitation delivery, including inpatient, outpatient, home-based, and remote arrangements. For stable COPD, it describes outpatient programs that may extend over six to eight weeks, with supervised exercise sessions and appropriate individualization.

These provisions are important because they recognize the need to assess functional capacity and support patients beyond pharmacological treatment alone. They also provide a basis for healthcare organizations to consider how rehabilitation can be incorporated into established COPD care pathways.

An example rehabilitation schedule, however, should not be treated as an identical prescription for every patient. Program design and delivery depend on clinical assessment, rehabilitation goals, professional expertise, and the resources and responsibilities of the healthcare facility.

International guidance, particularly GOLD 2026 and the American Thoracic Society's pulmonary rehabilitation recommendations, can complement the Vietnamese guideline by providing additional evidence and implementation perspectives.

These international sources do not automatically override Vietnamese professional requirements or authorize clinical activities outside the applicable legal framework.

The Law on Medical Examination and Treatment No. 15/2023/QH15, as amended, and its implementing regulations govern medical examination, treatment, professional practice, and healthcare facility responsibilities. The consolidated legal text issued as Document No. 26/VBHN-VPQH on February 26, 2026, provides a relevant reference.

Viet Nam's Law on Disease Prevention No. 114/2025/QH15, effective July 1, 2026, also provides a broader framework for preventing noncommunicable diseases and addressing health-related risk factors. Nevertheless, public health education and preventive activities must be distinguished from regulated clinical examination and treatment.

Lifestyle Medicine does not create a separate legal authorization to diagnose COPD, prescribe respiratory medicines, perform pulmonary function testing, or deliver specialized pulmonary rehabilitation.

For professional educational organizations, maintaining this distinction is essential. Supporting understanding of clinical evidence is different from independently providing or authorizing clinical services.

Improving Access to Pulmonary Rehabilitation

An intervention can have strong evidence of clinical benefit while remaining difficult for some patients to access.

Pulmonary rehabilitation illustrates this challenge because participation may require repeated visits, trained professionals, suitable assessment facilities, and continuing support. Travel distance, transportation difficulties, employment commitments, financial constraints, physical limitations, and uncertainty about rehabilitation may affect whether a patient begins or completes a program.

Healthcare organizations may encounter additional challenges involving staffing, equipment, referral arrangements, and the organization of follow-up services.

A mixed-methods systematic review by Qin and colleagues, published in BMC Pulmonary Medicine in July 2025, examined barriers and facilitators to pulmonary rehabilitation participation among people with COPD.

The review identified interacting psychological, interpersonal, and structural factors. These included anxiety, health literacy, communication with healthcare professionals, family support, financial constraints, and differences in access to services.

Such findings can help inform service evaluation, although their applicability to specific Vietnamese healthcare settings needs to be assessed rather than assumed.

Alternative rehabilitation models may be appropriate for selected patients. The American Thoracic Society's 2023 guideline recommends offering people with stable chronic respiratory disease a choice between center-based pulmonary rehabilitation and telerehabilitation, based on the available evidence.

Telerehabilitation may reduce certain barriers to participation, particularly for patients who have difficulty traveling to rehabilitation facilities. However, the evidence supporting center-based rehabilitation remains more extensive, and remote delivery should be considered an alternative rather than a replacement for all established programs.

Remote rehabilitation also requires more than access to exercise videos or online health coaching. Appropriate patient selection, clinical assessment, individualized training, supervision arrangements, monitoring when indicated, and procedures for responding to clinical concerns remain important.

Any such service developed in Viet Nam would need to comply with the applicable healthcare, professional practice, and service delivery requirements.

For healthcare organizations, improving access begins with understanding what happens along the patient's pathway.

A referral does not necessarily mean that a patient attended rehabilitation. Attendance does not automatically mean that the planned intervention was completed, and program completion does not by itself demonstrate lasting functional benefit.

Service evaluation may therefore consider how eligible patients are identified, how many receive appropriate referrals, how many begin and complete rehabilitation, what barriers affect participation, and whether clinically meaningful changes occur in symptoms, physical capacity, and daily functioning.

These questions connect the evidence supporting rehabilitation with the actual experience of patients receiving care. They can also help healthcare organizations identify which parts of a rehabilitation pathway need improvement, rather than measuring success solely by the number of referrals or completed sessions.

The objective should be to improve access without compromising the clinical assessment, supervision, or professional responsibilities necessary for safe and effective rehabilitation.

Implications for the Vietnam Lifestyle Medicine Alliance

COPD illustrates why evidence-based Lifestyle Medicine should be integrated into established healthcare rather than presented as a separate solution to chronic disease.

Smoking cessation can slow the decline in lung function associated with continued tobacco exposure. Pulmonary rehabilitation can improve exercise capacity and reduce the functional impact of breathlessness. Appropriate nutritional support may help patients experiencing nutritional depletion or muscle weakness, while reducing harmful environmental exposures can contribute to respiratory protection.

These interventions address different aspects of care, and their value depends on selecting and delivering them appropriately.

For VLMA, an important contribution is to support healthcare professionals in understanding the evidence, limitations, and practical requirements of lifestyle-related interventions in chronic respiratory disease.

Professional education and scientific knowledge exchange could explore pulmonary rehabilitation, tobacco cessation, the assessment of functional outcomes, environmental determinants of respiratory health, and the coordination of supportive care.

Such work should involve appropriate respiratory and rehabilitation expertise where relevant and remain consistent with Vietnamese professional and legal requirements.

VLMA is a physician-led professional platform operated by Vietnam Lifestyle Medicine Alliance Company Limited. Its activities are directed toward evidence-based education, professional knowledge exchange, capability development, and collaboration. VLMA does not independently provide COPD diagnosis, respiratory treatment, pulmonary rehabilitation, or other clinical services.

Its potential contribution lies in helping healthcare professionals critically understand the available evidence and consider how relevant interventions may be incorporated into appropriate healthcare pathways.

International evidence may establish that an intervention is effective under certain conditions, but its feasibility, accessibility, and outcomes in specific Vietnamese settings still require local evaluation. Supporting that translation from scientific evidence to practical understanding is an appropriate role for a professional educational platform.

Living Better With COPD

For someone with COPD, meaningful improvement may mean walking farther without stopping, returning to an activity they had abandoned, feeling less anxious about breathlessness, or managing daily tasks with greater independence.

These improvements matter even when persistent airflow obstruction remains and the underlying disease cannot be cured.

Evidence-based Lifestyle Medicine can contribute through tobacco cessation, appropriate physical activity, nutritional support, and efforts to reduce harmful exposures. Pulmonary rehabilitation offers a particularly important example of how structured exercise, education, and behavior-change support can work together within comprehensive clinical care.

These interventions cannot replace accurate diagnosis, appropriate respiratory medication, vaccination, oxygen therapy when indicated, treatment of exacerbations, or specialist care. Nor should responsibility for COPD be placed entirely on individuals when exposure to harmful substances, working conditions, household circumstances, and access to healthcare may lie partly beyond their control.

The updated Vietnamese guideline provides a timely foundation for strengthening comprehensive COPD management. The continuing challenge is to translate that guidance into care that is clinically appropriate, accessible, coordinated, and responsive to patients' needs.

For VLMA, the contribution of Lifestyle Medicine is not to promise a cure for COPD, but to support a more complete understanding of how evidence-based lifestyle-related interventions can help people reduce avoidable risks, maintain functional capacity, and live as well as possible with chronic respiratory disease.

Selected References

1. Ministry of Health of Viet Nam. Decision No. 2131/QĐ-BYT Issuing the Professional Guideline for Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease. July 14, 2026.

2. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Prevention, Diagnosis, and Management of Chronic Obstructive Pulmonary Disease: 2026 Report. GOLD; 2026.

3. World Health Organization. Chronic Obstructive Pulmonary Disease (COPD). Fact sheet. Updated June 10, 2026.

4. Rochester CL, Alison JA, Carlin B, et al. Pulmonary Rehabilitation for Adults With Chronic Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine. 2023;208(4)–e26. DOI: 10.1164/rccm.202306-1066ST.

5. World Health Organization. WHO Clinical Treatment Guideline for Tobacco Cessation in Adults. Geneva: World Health Organization; 2024. ISBN: 978-92-4-009643-1.

6. World Health Organization. Household Air Pollution. Fact sheet. Updated December 16, 2025.

7. Phan TT, Vu GV, Ngo CQ. Management of Chronic Obstructive Pulmonary Disease in Vietnam During the COVID-19 Period: Current Situation and Challenges. Tuberculosis and Respiratory Diseases. 2025;88(2):322–333. DOI: 10.4046/trd.2024.0140.

8. Dang KD, Vu LT, Tran SV. Treatment Adherence and Treatment Effectiveness in Stable Chronic Obstructive Pulmonary Disease Among Outpatients at An Giang Province, Vietnam. Pulmonary Medicine. 2026;2026:7201063. Published September 6, 2026. DOI: 10.1155/pm/7201063.

9. Qin H, Jia P, Yan Q, et al. Barriers and Facilitators to Pulmonary Rehabilitation in COPD: A Mixed-Methods Systematic Review. BMC Pulmonary Medicine. 2025;25:314. DOI: 10.1186/s12890-025-03769-9.

10. National Assembly of Viet Nam. Law on Medical Examination and Treatment No. 15/2023/QH15. January 9, 2023, as amended. Consolidated Document No. 26/VBHN-VPQH, February 26, 2026.

11. National Assembly of Viet Nam. Law on Disease Prevention No. 114/2025/QH15. December 10, 2025. Effective July 1, 2026.

12. National Assembly of Viet Nam. Resolution No. 173/2024/QH15. November 30, 2024, including provisions concerning electronic cigarettes and heated tobacco products.

13. Government of Viet Nam. Decree No. 90/2026/NĐ-CP on Administrative Sanctions in the Health Sector. March 30, 2026. Effective May 15, 2026.

14. Rea BL, Cheema S, Lanza S, et al. Lifestyle Medicine Core Competencies: 2025 Update. American Journal of Lifestyle Medicine. 2026;20(3):443–451. First published online October 28, 2025. DOI: 10.1177/15598276251379821.

Editorial and Professional Scope Note

This article presents an educational and professional perspective of the Vietnam Lifestyle Medicine Alliance on the contribution and limitations of evidence-based Lifestyle Medicine in chronic obstructive pulmonary disease care, based on information reviewed through October 30, 2026.

It is intended for professional information, education, and scientific knowledge exchange. It does not constitute a clinical practice guideline, individualized medical advice, a diagnostic or treatment protocol, a pulmonary rehabilitation prescription, or an authoritative interpretation of Vietnamese law.

Vietnam Lifestyle Medicine Alliance (VLMA) is a physician-led professional platform operated by Vietnam Lifestyle Medicine Alliance Company Limited. VLMA is not a licensed medical examination or treatment facility, respiratory care provider, pulmonary rehabilitation provider, medical licensing authority, or healthcare accreditation organization. It does not independently diagnose COPD, perform pulmonary function testing, prescribe respiratory medicines, treat acute exacerbations, or provide specialized clinical rehabilitation.

Clinical assessment, diagnosis, treatment, rehabilitation, and follow-up must be undertaken by appropriately qualified and authorized healthcare professionals and facilities within their applicable scopes of practice and in accordance with relevant Vietnamese requirements.

Lifestyle-related interventions should not delay or replace necessary medical assessment, prescribed respiratory treatment, vaccination, oxygen therapy when indicated, emergency care, or specialist services. Decisions concerning exercise, tobacco cessation treatment, nutrition, medication, environmental exposure management, and rehabilitation require appropriate clinical assessment and individualized care.

International guidelines, scientific studies, and professional frameworks are cited for educational purposes. Their inclusion does not imply that they automatically have regulatory force in Viet Nam or that VLMA has independently adopted, provided, evaluated, endorsed, or certified any COPD management or rehabilitation program discussed in this article.

The hypothetical patient examples are illustrative and do not describe actual VLMA clinical activities or identifiable patients.